Jonas Salk was an American physician and medical researcher best known for developing the first widely successful polio vaccine. In the early 1950s, polio caused fear because it could paralyze children and adults, sometimes requiring iron lungs to help patients breathe. Salk's inactivated polio vaccine was announced as safe and effective in 1955 after one of the largest medical trials in history.
His work showed how laboratory science, clinical testing, and public trust can change the course of a disease.
Key Facts
- Jonas Salk lived from 1914 to 1995 and trained as a physician and virologist.
- The Salk vaccine used inactivated poliovirus, meaning the virus was killed so it could not reproduce in the body.
- A vaccine works by training the immune system to recognize a pathogen before a real infection occurs.
- The 1954 polio vaccine field trial involved more than 1 million children and helped prove the vaccine's effectiveness.
- The inactivated polio vaccine was licensed in the United States in 1955 and became part of mass vaccination campaigns.
- Vaccine impact can be estimated with percent reduction = (old cases - new cases) / old cases × 100%.
Vocabulary
- Polio
- Polio is a viral disease that can attack the nervous system and cause paralysis in some infected people.
- Inactivated vaccine
- An inactivated vaccine contains a killed pathogen that cannot reproduce but can still trigger an immune response.
- Antibody
- An antibody is a protein made by the immune system that binds to a specific part of a pathogen.
- Herd immunity
- Herd immunity occurs when enough people are immune to a disease that its spread through a community becomes much harder.
- Clinical trial
- A clinical trial is a carefully designed study that tests whether a medical treatment is safe and effective in people.
Common Mistakes to Avoid
- Thinking the Salk vaccine gave people active polio, which is wrong because it used inactivated virus that could not reproduce in the body.
- Confusing Salk's vaccine with the later oral polio vaccine, which is wrong because Salk's version was an injected inactivated vaccine while Albert Sabin's was an oral live attenuated vaccine.
- Assuming one scientist worked alone to end polio, which is wrong because Salk's breakthrough depended on research teams, trial volunteers, public health workers, and vaccination campaigns.
- Ignoring vaccination coverage when judging disease decline, which is wrong because a vaccine only protects communities well when enough people receive it.
Practice Questions
- 1 In a town, annual polio cases dropped from 200 to 12 after a vaccination campaign. Calculate the percent reduction in cases.
- 2 A school has 1,200 students, and 1,050 receive the polio vaccine. What percentage of the student body is vaccinated?
- 3 Explain why refusing to patent the polio vaccine helped support public health, and describe one challenge that still had to be solved to get the vaccine to people.